8-K: Maximus FY25 Results: Margin Expansion, Strong Cash Flow

Maximus reported strong fiscal year 2025 financial results with revenue growth, significant margin expansion, robust cash generation, and provided optimistic fiscal year 2026 guidance.

Summary

• Full year 2025 revenue increased 2.4% to $5.43 billion, with organic growth of 3.9%, driven by high demand for clinical services within the U.S. Federal Services Segment.
• Operating margin expanded to 9.7% (from 9.2% in FY2024) and adjusted EBITDA margin to 12.9% (from 11.6% in FY2024), reflecting year-over-year improvement.
• Diluted earnings per share rose to $5.51 (from $4.99 in FY2024), and adjusted diluted EPS to $7.36 (from $6.11 in FY2024).
• Cash flows from operating activities totaled $429 million, and free cash flow was $366 million for the full fiscal year.
• The company repurchased 5.8 million shares for $457 million during the year, reducing the leverage ratio to 1.5x at September 30, 2025.
• Maximus declared a quarterly cash dividend of $0.30 per share, payable on December 1, 2025, to shareholders of record on November 14, 2025.
• Fiscal year 2026 guidance projects revenue between $5.225 billion and $5.425 billion, an adjusted EBITDA margin of approximately 13.7%, and adjusted diluted EPS between $7.95 and $8.25.

Sentiment

Score: 8

Explanation: The company reported strong financial performance for FY2025, exceeding initial expectations, with significant margin expansion, robust cash generation, and improved leverage. While some segments saw revenue declines, overall profitability and future outlook are positive, driven by strategic focus areas like U.S. Federal markets and AI automation. The positive FY2026 guidance further reinforces a strong outlook.

Positives

• Full year revenue increased 2.4% to $5.43 billion, with strong organic growth of 3.9%, exceeding initial expectations.
• Operating margin expanded to 9.7% and adjusted EBITDA margin to 12.9%, reflecting significant year-over-year improvement.
• Diluted EPS increased to $5.51 and adjusted diluted EPS to $7.36, demonstrating enhanced operating profitability.
• Strong cash flows from operating activities ($429 million) and free cash flow ($366 million) for the full year, with Q4 free cash flow at $642 million.
• Significant share repurchases totaling $457 million for 5.8 million shares, indicating commitment to shareholder returns.
• Leverage ratio improved substantially to 1.5x at September 30, 2025, from 2.1x at June 30, 2025, providing meaningful financial flexibility.
• U.S. Federal Services Segment revenue grew 12.1% organically to $3.07 billion, with its operating margin expanding to 15.3%.
• Outside the U.S. Segment operating margin improved to 3.7% from 1.2%, now operating within its 3% to 7% target range.
• Days Sales Outstanding (DSO) improved significantly to 62 days at September 30, 2025, from 96 days at June 30, 2025, demonstrating strong collections.
• Fiscal year 2026 guidance projects higher adjusted EBITDA margin (approximately 13.7%) and adjusted diluted EPS ($7.95-$8.25) compared to FY2025 actuals.

Negatives

• Cash flows from operating activities decreased to $429 million in FY2025 from $515 million in FY2024.
• Free cash flow decreased to $366 million in FY2025 from $401 million in FY2024.
• U.S. Services Segment revenue decreased by 7.7% to $1.76 billion, primarily due to the absence of temporary excess Medicaid-related volumes from the prior year.
• U.S. Services Segment operating margin decreased to 9.7% from 12.9% in the prior fiscal year, impacted by $16 million in severance charges booked in Q4 FY2025.
• Outside the U.S. Segment revenue decreased 8.7% due to divestitures of multiple employment services businesses.
• The book-to-bill ratio was 0.9x on a trailing twelve-month basis, indicating that new contract awards were slightly less than revenue recognized.

Risks

• Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those indicated.
• A summary of risk factors can be found in Item 1A, 'Risk Factors' in the Annual Report on Form 10-K for the fiscal year ended September 30, 2024, filed on November 21, 2024.
• Risk factors are supplemented by those set forth in Part II, Item 1A 'Risk Factors' in the Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, filed with the SEC on May 8, 2025.

Future Outlook

Maximus is establishing fiscal year 2026 guidance, expecting revenue between $5.225 billion and $5.425 billion, an adjusted EBITDA margin of approximately 13.7%, and adjusted diluted earnings per share ranging from $7.95 to $8.25. Free cash flow is projected to be between $450 million and $500 million. The company is prioritizing expansion in U.S. Federal markets, preparing for opportunities from recent Federal legislation, and deploying AI-enabled automation designed to drive productivity and operating leverage, aiming for growth acceleration in 2027 and beyond.

Management Comments

• "Fiscal 2025 was a year of significant achievement for Maximus, as our teams skillfully navigated shifting priorities, seized opportunities to step up for our customers, and ultimately delivered revenue growth and profitability well above our expectations at the beginning of the fiscal year."
• "Our performance underscores the essential nature of the services we provide, and the trust customers place in us to deliver meaningful outcomes."
• "For fiscal 2026, Maximus is prioritizing expansion in U.S. Federal markets, preparing for opportunities from recent Federal legislation, and deploying AIenabled automation designed to drive productivity and operating leverage that we believe will enable growth acceleration in 2027 and beyond."

Industry Context

Maximus operates as a leading strategic partner to government agencies, providing tech-enabled services and business process management solutions. The company's strong performance in U.S. Federal markets, particularly clinical programs, aligns with ongoing government needs for efficient public service delivery. The emphasis on AI-enabled automation reflects a broader industry trend towards leveraging technology for productivity and operational efficiency in government contracting and service delivery, positioning Maximus to capitalize on these evolving demands.

Stakeholder Impact

• Shareholders benefited from increased diluted EPS, a declared quarterly cash dividend of $0.30 per share, and significant share repurchases totaling $457 million. The improved leverage ratio and positive FY2026 guidance suggest continued financial stability and potential for future returns.
• Employees in the U.S. Services segment were impacted by $16 million in severance charges booked in Q4 FY2025, indicating workforce adjustments.
• Customers (government agencies) continue to place trust in Maximus to deliver essential services, with the company's performance underscoring its ability to provide meaningful outcomes.

Next Steps

• Prioritizing expansion in U.S. Federal markets.
• Preparing for opportunities from recent Federal legislation.
• Deploying AI-enabled automation designed to drive productivity and operating leverage.
• Aiming for growth acceleration in 2027 and beyond.
• Hosting a conference call on November 20, 2025, at 9:00 a.m. ET to discuss results and outlook.

Key Dates

Recommendation

Maximus delivered a strong fiscal year 2025, surpassing initial expectations with robust revenue growth, significant margin expansion, and excellent cash flow generation. The substantial reduction in the leverage ratio and aggressive share repurchase program demonstrate effective capital management and commitment to shareholder returns. While the U.S. Services segment faced headwinds, the strong performance of the U.S. Federal Services segment and strategic focus on AI-enabled automation and federal market expansion position the company for continued growth. The positive FY2026 guidance, projecting further margin expansion and EPS growth, indicates a healthy outlook and strong operational momentum, making it an attractive investment.

Keywords

Government Services, Business Process Management, Technology Solutions, Public Services, U.S. Federal Services, Clinical Programs, Medicaid, AI Automation, Financial Results, Earnings, EBITDA, Cash Flow, Share Repurchase, Dividend